Search Browse Earnings

BeOne Medicines Ltd. — SlamSEC

BeOne Medicines Ltd.

Nasdaq:ONCOTC:BEIGF

Pharmaceutical Preparations·BASEL

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

$2.5B

+73.7% YoY

FY 2025

Adj. EBITDA

-$1.1B

-45.6% margin

FY 2025

Net Income

-$881.7M

-35.9% margin

FY 2025

EPS (Diluted)

-$0.65

FY 2025

Stock Price

$301.24

+2.8%

2026-03-06

52W Range

$196.45 – $385.22

P/E Ratio

-463.4x

Market Cap

$434.5B

Cash

$3.2B

FY 2025

Total Debt

$175.5M

FY 2025

Net Cash

$3.0B

FY 2025

Enterprise Value

$431.5B

Debt / EBITDA

2.7x

FY 2025

EV / EBITDA

-385.2x

Employees

12K

FY 2025

CEO

Oyler John